We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

36 hedge funds and large institutions have $6.14M invested in Lumos Pharma, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 36 → 36 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

18% less capital invested

Capital invested by funds: $7.52M → $6.14M (-$1.38M)

Holders
36
Holders Change
–
Holders Change %
0%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$111K
2
AI
Acuitas Investments
Washington
+$45.7K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$41.6K
4
Citadel Advisors
Citadel Advisors
Florida
+$39.4K
5
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$12.4K

Top Sellers

Rank Fund Capital Flow
1
Blackstone Inc
Blackstone Inc
New York
-$735K
2
BCM
Bridgeway Capital Management
Texas
-$59.3K
3
Osaic Holdings
Osaic Holdings
Arizona
-$13.2K
4
Two Sigma Investments
Two Sigma Investments
New York
-$11.3K
5
Renaissance Technologies
Renaissance Technologies
New York
-$10.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
1
Wells Fargo
California
$1.17M -$4.45K -1,500 -0.4%
Goldman Sachs
2
Goldman Sachs
New York
$1.15M +$3 +1 +0%
Vanguard Group
3
Vanguard Group
Pennsylvania
$688K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$615K -$10.7K -3,600 -2%
AI
5
Acuitas Investments
Washington
$397K +$45.7K +15,407 +12%
JFG
6
Jefferies Financial Group
New York
$340K – – –
LPC
7
Lion Point Capital
New York
$256K – – –
Blackstone Inc
8
Blackstone Inc
New York
$222K -$735K -247,928 -76%
GWM
9
Greenwich Wealth Management
Connecticut
$215K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$134K – – –
BlackRock
11
BlackRock
New York
$116K -$6.98K -2,356 -5%
Two Sigma Investments
12
Two Sigma Investments
New York
$109K -$11.3K -3,802 -9%
Millennium Management
13
Millennium Management
New York
$106K +$111K +37,579 New
Two Sigma Advisers
14
Two Sigma Advisers
New York
$90K +$10.7K +3,600 +13%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$83.5K +$41.6K +14,053 +90%
BCM
16
Bridgeway Capital Management
Texas
$78K -$59.3K -20,000 -42%
MAM
17
Marquette Asset Management
Minnesota
$72.6K – – –
Envestnet Asset Management
18
Envestnet Asset Management
Illinois
$45.4K +$12.4K +4,173 +35%
PAG
19
Private Advisor Group
New Jersey
$45.2K – – –
Citadel Advisors
20
Citadel Advisors
Florida
$37.5K +$39.4K +13,286 New
Bank of New York Mellon
21
Bank of New York Mellon
New York
$33.4K – – –
WAOI
22
Wealth Advisors of Iowa
Iowa
$33K – – –
State Street
23
State Street
Massachusetts
$31.7K – – –
KFI
24
Key Financial Inc
Pennsylvania
$30.8K – – –
PAG
25
Paladin Advisory Group
Iowa
$12.5K – – –
1
2

LUMO Hedge Fund Activity: Q1 2024 in Review

36 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q1 2024, worth a combined $6.14M — down 18% from $7.52M a quarter earlier.

Fund positioning in LUMO was balanced in Q1 2024: 2 funds opened new positions, 2 closed out, 8 added to existing stakes and 8 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $111K. The largest seller was Blackstone Inc, cutting an estimated $735K.

  • 36 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $6.14M of Lumos Pharma, Inc. Common Stock stock for Q1 2024, down 18% quarter-over-quarter.
  • 2 funds opened new Lumos Pharma, Inc. Common Stock positions in Q1 2024 and 2 closed out, a net change of 0 holders.
  • The largest Lumos Pharma, Inc. Common Stock buyer in Q1 2024 was Millennium Management, an estimated $111K added.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q1 2024 was Blackstone Inc, an estimated $735K sold.

Based on aggregated 13F filings for Q1 2024.